News 2015-03-26
Passion at Chongqing International Marathon
75 athletes from Porton joined in the Chongqing International Marathon held on Mar. 22nd, 2015. It’s the first time to participate the marathon race for most of them, but they all exceeded the result estimated themselves before the race. They all expressed the marathon’s spirit of perseverance and transcending oneself. As the CEO Oliver Ju said, the colorful life comes from the constant self-challenges and Porton’s future comes from constantly transcend ourselves.
Others
More
News 2025-04-16
Porton Advanced's End-to-End CDMO Solutions Accelerates IND Approval of Tasly's Innovative Dual-Targeting CAR-T Therapy
April 12, 2025 - Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD’s Innovative Dual-Targeting CAR-T Therapy, "P134 Cell Injection," which has received Investigational New Drug (IND) approval from China's National Medical Products Administration (NMPA) (Approval No.: 2025LP01030). This breakthrough CAR-T therapy is indicated for recurrent glioblastoma (GBM).
News 2025-04-11
Porton Newsletter - March 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities
